Under pressure from the Trump administration’s investigation into gender-affirming care for minors, Michigan Medicine announced it would halt the provision of hormone therapy and puberty blockers for patients under 19. This decision, prompted by federal subpoenas and escalating threats, has caused significant concern among parents and advocacy groups. The hospital system stated it will continue to offer other support services but is facing potential legal issues and civil rights violations. This comes amidst the backdrop of a broader national debate surrounding the legality and necessity of such care for transgender youth, with the American Medical Association and American Academy of Pediatrics supporting gender-affirming care.
Read More
The Turkish Health Ministry has implemented new restrictions on hormone medications used in gender-affirming care, specifically targeting individuals under the age of 21. The directive, issued through the Medicines and Medical Devices Agency, cites the government’s “Year of the Family” campaign and the protection of “cultural and moral values” as justification. The restricted medications include testosterone-based drugs, GnRH analogues, and high-dose estrogen products, although they remain accessible for other medical conditions. This policy change follows an earlier restriction and aligns Turkey with other countries limiting access to hormone replacement therapy, raising concerns among experts about the potential impact on the physical and mental well-being of transgender individuals.
Read More
Brazil’s CFM council raised the minimum age for transgender individuals to access hormone therapy from 16 to 18, also prohibiting puberty blockers for minors with gender dysphoria. The council further increased the minimum age for certain gender reassignment surgeries to 21. This decision follows similar actions in other countries, including Argentina, and mirrors growing global debate surrounding the provision of such treatments to minors. The move reflects a broader conservative trend impacting transgender rights, fueled by ongoing political and legal challenges worldwide.
Read More
John Q. Hosedrinker